Related Experiment Video
Updated: Aug 13, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Antithrombin activity in children with chylothorax
Vera Bernet-Buettiker1, Katharina Waldvogel, Vincenzo Cannizzaro
1Division of Neonatology and Intensive Care, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland. vera.bernet@kispi.unizh.ch
Insights
Children with chylothorax after heart surgery experience increased antithrombin loss. This may elevate their risk for thrombosis, suggesting antithrombin substitution could be beneficial.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Hematology
Background:
- Chylothorax is a complication following cardiac surgery in children.
- Antithrombin is a key protein in the coagulation cascade.
Purpose of the Study:
- To investigate antithrombin levels in children with chylothorax post-cardiac surgery.
- To assess the association between antithrombin loss and thrombosis risk.
Main Methods:
- Assayed antithrombin activity in plasma and pleural effusion samples.
- Compared children with chylous effusion to those with non-chylous effusion.
Main Results:
- Significantly higher antithrombin activity in chylous pleural effusion compared to non-chylous.
- Significantly lower antithrombin levels in the plasma of children with chylothorax.
- Higher incidence of thrombosis in children with chylothorax.
Conclusions:
- Children with chylothorax exhibit increased antithrombin loss.
- This loss may predispose them to thrombosis.
- Consider antithrombin substitution in critically ill children with chylothorax.
Objective:
To determine whether increased antithrombin loss is present in children with chylothorax after cardiac surgery.
Methods:
Plasma and pleural effusion samples of children with chylous and non-chylous pleural effusion were assayed for antithrombin activity.
Results:
Ten children with chylothorax and five children with non-chylous pleural effusion were investigated. There was statistically significant increase in mean antithrombin activity in chylous samples (32.2+/-11.4%) compared to non-chylous samples (14.4+/-13.9%), and significant decrease in plasma of children with chylothorax (44.6+/-15.4%) compared to children with non-chylous pleural effusion (69.9+/-22.4%). Seven of 10 children with chylous and none of the children without chylous developed thrombosis (p<0.007).
Conclusions:
Increased loss of antithrombin is present in children with chylothorax, potentially predisposing these children to an increased risk of thrombosis. Repeated antithrombin substitution should be considered in critically ill children with chylothorax.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...